IFP Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,440
| Closed | -$586K | – | 5053 |
|
|
2025
Q1 | $586K | Sell |
4,440
-337
| -7% | -$42K | 0.02% | 723 |
|
|
2024
Q4 | $399K | Buy |
4,777
+2,348
| +97% | +$193K | 0.01% | 821 |
|
|
2024
Q3 | $178K | Buy |
+2,429
| New | +$183K | 0.01% | 1144 |
|
|
2024
Q2 | – | Sell |
-17
| Closed | -$1.18K | – | 3364 |
|
|
2024
Q1 | $1.18K | Buy |
+17
| New | +$1.17K | ﹤0.01% | 2828 |
|
|
2023
Q3 | – | Sell |
-19
| Closed | -$1.2K | – | 3586 |
|
|
2023
Q2 | $1.2K | Buy |
+19
| New | +$1.18K | ﹤0.01% | 3033 |
|
|
2022
Q4 | – | Sell |
-401
| Closed | -$10K | – | 4876 |
|
|
2022
Q3 | $10K | Sell |
401
-200
| -33% | -$10.4K | ﹤0.01% | 3679 |
|
|
2022
Q2 | $15K | Hold |
601
| – | – | ﹤0.01% | 3114 |
|
|
2022
Q1 | $15K | Buy |
+601
| New | +$31.2K | ﹤0.01% | 3114 |
|
|
2017
Q3 | – | Sell |
-300
| Closed | -$4K | – | 4238 |
|
|
2017
Q2 | $4K | Hold |
300
| – | – | ﹤0.01% | 3549 |
|
|
2017
Q1 | $5K | Hold |
300
| – | – | ﹤0.01% | 3339 |
|
|
2016
Q4 | $5K | Hold |
300
| – | – | ﹤0.01% | 3335 |
|
|
2016
Q3 | $5K | Sell |
300
-200
| -40% | -$8.09K | ﹤0.01% | 3264 |
|
|
2016
Q2 | $19K | Buy |
+500
| New | +$18K | ﹤0.01% | 2388 |
|
Other funds holding ITCI
KIM
HNB